Drug Profile
Paclitaxel releasing balloon - BIOTRONIK
Alternative Names: Drug-eluting balloon - BIOTRONIK; Pantera Lux Paclitaxel Releasing Balloon; Passeo-18 Lux; Passeo-18 Lux DCBLatest Information Update: 15 Jan 2022
Price :
$50
*
At a glance
- Originator BIOTRONIK
- Class Antineoplastics; Diterpenes; Paclitaxels; Skin disorder therapies; Small molecules; Taxanes; Vascular disorder therapies
- Mechanism of Action Mitosis inhibitors; Proto-oncogene protein c-bcl-2 inhibitors; Tubulin polymerisation promoters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Coronary artery restenosis
- Discontinued Ischaemic heart disorders; Peripheral arterial disorders
Most Recent Events
- 24 Sep 2021 Discontinued - Phase-II for Ischaemic heart disorders in Australia (Intracoronary)
- 24 Sep 2021 Discontinued - Phase-II for Peripheral arterial disorders in Belgium, Germany, Austria (Intra-arterial)
- 01 Aug 2020 Biotronik (Beijing) Medical Device completes BIOTRONIK trial for Peripheral arterial disorders in China (NCT02912715)